tiprankstipranks
Upexi assumed with a Buy at EF Hutton
The Fly

Upexi assumed with a Buy at EF Hutton

EF Hutton analyst Michael Albanese assumed coverage of Upexi with a Buy rating and $7 price target. Upexi, formerly Grove, has shifted focus from a single product to be a wider product distribution and brand enterprise while evolving into an online reselling business, Albanese tells investors. He sees building momentum with its VitaMedica, Interactive, Cygnet and LuckyTail assets and thinks management has shown an ability to acquire, integrate and scale "accretive acquisitions" to add to its brands, Albanese added.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on UPXI:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles